We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.7B
Cap. Flow %
9.4%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Technology 14.64%
3 Consumer Discretionary 12.82%
4 Industrials 10.92%
5 Communication Services 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.47T
$440M 2.43%
2,495,476
+678,447
+37% +$120M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.26T
$324M 1.79%
6,145,540
+1,810,800
+42% +$93.5M
JNJ icon
3
Johnson & Johnson
JNJ
$641B
$289M 1.6%
2,067,353
-360,306
-15% -$50.2M
ZTS icon
4
Zoetis
ZTS
$31.7B
$258M 1.42%
3,577,907
-105,989
-3% -$7.28M
BSX icon
5
Boston Scientific
BSX
$67.7B
$256M 1.41%
10,310,777
+7,929,843
+333% +$219M
PFE icon
6
Pfizer
PFE
$159B
$235M 1.3%
6,845,815
+1,656,002
+32% +$56.5M
SPGI icon
7
S&P Global
SPGI
$131B
$215M 1.19%
1,267,468
+212,393
+20% +$34.7M
TWX
8
DELISTED
Time Warner Inc
TWX
$200M 1.11%
+2,188,772
New +$207M
DGX icon
9
Quest Diagnostics
DGX
$26.8B
$183M 1.01%
1,857,599
+1,700,001
+1,079% +$161M
DHR icon
10
Danaher
DHR
$152B
$182M 1%
2,209,225
-1,125
-0.1% -$91.5K
MSFT icon
11
Microsoft
MSFT
$3.82T
$158M 0.88%
1,850,930
+988,797
+115% +$81.1M
CVS icon
12
CVS Health
CVS
$120B
$153M 0.85%
+2,114,629
New +$154M
UNH icon
13
UnitedHealth
UNH
$355B
$150M 0.83%
680,815
+400,988
+143% +$85M
TMUS icon
14
T-Mobile US
TMUS
$194B
$140M 0.77%
2,197,442
+1,741,950
+382% +$106M
SEE
15
DELISTED
Sealed Air
SEE
$138M 0.76%
2,798,716
-433,785
-13% -$19.9M
MRVL icon
16
Marvell Technology
MRVL
$197B
$138M 0.76%
6,417,455
+4,825,681
+303% +$98.4M
BABA icon
17
Alibaba
BABA
$295B
$133M 0.73%
771,097
+463,042
+150% +$83M
LVS icon
18
Las Vegas Sands
LVS
$29.3B
$133M 0.73%
1,908,339
+727,705
+62% +$48.5M
CSL icon
19
Carlisle Companies
CSL
$14.1B
$132M 0.73%
1,160,888
-103,556
-8% -$11.3M
PM icon
20
Philip Morris
PM
$299B
$131M 0.72%
1,237,327
+28,553
+2% +$3.04M
PTC icon
21
PTC
PTC
$17.2B
$129M 0.71%
2,123,984
-98,309
-4% -$6.1M
A icon
22
Agilent Technologies
A
$43.3B
$125M 0.69%
1,860,498
+819,527
+79% +$55.3M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$138B
$123M 0.68%
822,888
+256,709
+45% +$38M
NVS icon
24
Novartis
NVS
$291B
$120M 0.66%
1,591,500
+623,156
+64% +$47M
ABT icon
25
Abbott
ABT
$195B
$118M 0.65%
2,071,951
+945,904
+84% +$52.4M
1
2 3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.7B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.